明陽智能(601615.SH):能投集團等3名股東合計解除質押3450萬股
格隆匯1月9日丨明陽智能(601615.SH)公佈,公司於2020年1月9日收到控股股東關於能投集團股份解除質押、關於中山瑞信股份解除質押、關於中山博創部分股份解除質押的通知。
其中,能投集團解除質押1600萬股,中山瑞信解除質押600萬股,中山博創解除質押1250萬股。
截止公告日,共同控股股東合計持有公司股份約4.2699億股,佔公司總股本的30.95%。此次股份解除質押前,累計質押4102.2073萬股,佔其持有公司股份的9.61%,佔公司總股本的2.97%。此次股份解除質押後,共同控股股東累計質押公司股份652.2073萬股,佔其持有公司股份的1.53%,佔公司總股本的0.47%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.